Dupilumab Studied in Patients Hospitalized for COVID-19

TUESDAY, Aug. 16, 2022 -- Early research suggests that dupilumab, a monoclonal antibody used to treat asthma and eczema, may benefit patients hospitalized with moderate-to-severe COVID-19, according to a study published in the August issue of Open...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news